Key result
Infusion of human alpha-atrial natriuretic factor in dogs reduced mean arterial pressure and epinephrine release (to 49% of control at 0.1 microgram/kg/min, p<0.001) without tachycardia.
Why the study?
Does human alpha-atrial natriuretic factor inhibit sympathoadrenal activity in conscious dogs?
RCT (n=6)
randomized
Does human alpha-atrial natriuretic factor inhibit sympathoadrenal activity in conscious dogs?
p-value: p=<0.001
In a canine model, atrial natriuretic factor induces hypotension without reflex sympathetic activation, suggesting an inhibitory effect on sympathoadrenal activity.
Does not support clinical use of ANF; leaves open its role in human hypertension.
In six conscious, trained dogs, maintained on a normal sodium intake of 2 to 4 mEq/kg/day, sympathetic activity was assessed as the release rate of norepinephrine and epinephrine during 15-minute i.v. infusions of human alpha-atrial natriuretic factor. Mean arterial pressure (as a percentage of control +/- SEM) during randomized infusions of 0.03, 0.1, 0.3, or 1.0 microgram/kg/min was 99 +/- 1, 95 +/- 1 (p less than 0.05), 93 +/- 1 (p less than 0.01), or 79 +/- 6% (p less than 0.001), respectively, but no tachycardia and no augmentation of the norepinephrine release rate (up to 0.3 microgram/kg/min) were observed, which is in contrast to comparable hypotension induced by hydralazine or nitroglycerin. The release rate of epinephrine (control, 6.7 +/- 0.6 ng/kg/min) declined immediately during infusions of atrial natriuretic factor to a minimum of 49 +/- 5% of control (p less than 0.001) during 0.1 microgram/kg/min and to 63 +/- 5% (0.1 greater than p greater than 0.05) or 95 +/- 13% (not significant) during 0.3 or 1.0 microgram/kg/min. Steady state arterial plasma concentrations of atrial natriuretic factor were 39 +/- 10 pg/ml (n = 6) during infusions of saline and 284 +/- 24 pg/ml (n = 6) and 1520 +/- 300 pg/ml (n = 9) during 0.03 and 0.1 microgram/kg/min infusions of the factor.(ABSTRACT TRUNCATED AT 250 WORDS)
No takes yet. Share an insight, caveat, or question.
Holtz et al. (1987) reported an RCT. human alpha-atrial natriuretic factor vs. control (saline) was evaluated on sympathetic activity (release rate of norepinephrine and epinephrine) and mean arterial pressure (p=<0.001). Infusion of human alpha-atrial natriuretic factor in dogs reduced mean arterial pressure and epinephrine release (to 49% of control at 0.1 microgram/kg/min, p<0.001) without tachycardia.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: